Insight Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Insight Advisors's PFE Position: Q2 2026 in Review
Insight Advisors sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,786 shares — an estimated $219K sold.
Insight Advisors first reported a position in PFE in Q4 2020 and held it in 19 quarters. The position peaked at $1.62M in Q1 2023. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Insight Advisors reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Insight Advisors sold 7,786 Pfizer shares in Q2 2026, an estimated $219K.
- Insight Advisors first reported a position in Pfizer in Q4 2020 and held it in 19 quarters.
- Insight Advisors's Pfizer position peaked at $1.62M in Q1 2023.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Insight Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.